Wed, August 14, 2024

Andrew Fein Reiterated (ABOS) at Strong Buy and Held Target at $15 on, Aug 14th, 2024

Andrew Fein of HC Wainwright & Co., Reiterated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Aug 14th, 2024.

Andrew has made no other calls on ABOS in the last 4 months.



There is 1 other peer that has a rating on ABOS. Out of the 1 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Thursday, July 25th, 2024